- Home
- KYMR vs VAC Comparison
KYMR vs VAC Comparison
Compare KYMR & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- VAC
- Stock Information
- Founded
- KYMR 2015
- VAC 1984
- Country
- KYMR United States
- VAC United States
- Employees
- KYMR N/A
- VAC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- VAC Real Estate
- Sector
- KYMR Health Care
- VAC Finance
- Exchange
- KYMR Nasdaq
- VAC Nasdaq
- Market Cap
- KYMR 1.8B
- VAC 2.1B
- IPO Year
- KYMR 2020
- VAC N/A
- Fundamental
- Price
- KYMR $29.64
- VAC $65.80
- Analyst Decision
- KYMR Buy
- VAC Buy
- Analyst Count
- KYMR 15
- VAC 8
- Target Price
- KYMR $55.47
- VAC $92.25
- AVG Volume (30 Days)
- KYMR 650.3K
- VAC 580.1K
- Earning Date
- KYMR 05-09-2025
- VAC 05-07-2025
- Dividend Yield
- KYMR N/A
- VAC 4.80%
- EPS Growth
- KYMR N/A
- VAC 7.38
- EPS
- KYMR N/A
- VAC 5.85
- Revenue
- KYMR $58,885,000.00
- VAC $3,301,000,000.00
- Revenue This Year
- KYMR $32.80
- VAC $58.21
- Revenue Next Year
- KYMR $8.88
- VAC $3.22
- P/E Ratio
- KYMR N/A
- VAC $11.26
- Revenue Growth
- KYMR N/A
- VAC 4.26
- 52 Week Low
- KYMR $19.45
- VAC $49.22
- 52 Week High
- KYMR $53.27
- VAC $100.32
- Technical
- Relative Strength Index (RSI)
- KYMR 48.27
- VAC 51.55
- Support Level
- KYMR $28.06
- VAC $64.21
- Resistance Level
- KYMR $30.28
- VAC $73.16
- Average True Range (ATR)
- KYMR 1.65
- VAC 1.72
- MACD
- KYMR -0.19
- VAC -0.36
- Stochastic Oscillator
- KYMR 27.96
- VAC 17.78
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.